These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 884293)

  • 21. [Properties of intestinal monoamine oxidase in the rat].
    Verevkina IV; Asnina VV; Gorkin VZ
    Vopr Med Khim; 1982; 28(2):88-93. PubMed ID: 7080482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of the inhibition of rat liver monoamine oxidase-a by clorgyline after pretreatment with SKF 525A.
    Fowler CJ
    Med Biol; 1980 Oct; 58(5):285-7. PubMed ID: 7206835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 24. Lipid substitution of mitochondrial monoamine oxidase can lead to the abolition of clorgyline selective inhibition without alteration in the A/B ratio assessed by substrate utilisation.
    Houslay MD
    Biochem Pharmacol; 1980 Dec; 29(23):3211-3. PubMed ID: 7447959
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of mitochondrial monoamine oxidase of the rat uterus and liver by clorglyine, pargyline and harmine.
    Grosso DS; Gawienowski AM
    Biochem Pharmacol; 1976 Apr; 25(8):957-61. PubMed ID: 178322
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthetic rates of monoamine oxidase in rat liver after clorglyine or deprenyl administration.
    Egashira T; Kamijo K
    Jpn J Pharmacol; 1979 Aug; 29(4):677-80. PubMed ID: 119888
    [No Abstract]   [Full Text] [Related]  

  • 28. The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.
    Braestrup C; Andersen H; Randrup A
    Eur J Pharmacol; 1975 Nov; 34(1):181-7. PubMed ID: 1241962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline.
    Zsilla G; Földi P; Held G; Székely AM; Knoll J
    Pol J Pharmacol Pharm; 1986; 38(1):57-67. PubMed ID: 3020531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.
    Caramona MM; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):396-400. PubMed ID: 3921855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
    Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibition or rat heart type A monoamine oxidase by clorgyline as a method for the estimation of enzyme active centers.
    Fowler CJ; Callingham BA
    Mol Pharmacol; 1979 Sep; 16(2):546-55. PubMed ID: 514258
    [No Abstract]   [Full Text] [Related]  

  • 34. Observations on the inhibition of rat liver monoamine oxidase by clorgyline.
    Lyles GA; Greenawalt JW
    Biochem Pharmacol; 1977 Dec; 26(23):2269-74. PubMed ID: 588309
    [No Abstract]   [Full Text] [Related]  

  • 35. Monoamine oxidase inhibitors potentiate phenylethylamine effects in rhesus monkeys.
    Staub RA; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1980 Jun; 15(3):429-36. PubMed ID: 6769508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyramine and monoamine oxidase inhibitors as modulators of the mitochondrial membrane permeability transition.
    Marcocci L; De Marchi U; Salvi M; Milella ZG; Nocera S; Agostinelli E; Mondovi B; Toninello A
    J Membr Biol; 2002 Jul; 188(1):23-31. PubMed ID: 12172644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of alcohols on mitochondrial monoamine oxidase activity].
    Severina IS
    Biull Eksp Biol Med; 1975 Jan; 79(1):31-4. PubMed ID: 1111641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain.
    Kinemuchi H; Wakui Y; Arai Y; Kamijo K
    Biochem Pharmacol; 1980 Oct; 29(20):2871-4. PubMed ID: 6776962
    [No Abstract]   [Full Text] [Related]  

  • 39. [Determination of monoamine oxidase activity in a coupled reaction with alcohol dehydrogenase].
    Verevkina IV; Iakusheva MI
    Vopr Med Khim; 1977; (3):412-9. PubMed ID: 888410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.
    Fuller RW
    Biochem Pharmacol; 1968 Oct; 17(10):2097-106. PubMed ID: 5696879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.